Catalyst
Slingshot members are tracking this event:
Emergent BioSolutions (EBS) to complete Phase 1 study of Biothrax (Anthrax) vaccine in Pregnancy Registry in July 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EBS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 01, 2015
Occurred Source:
https://ichgcp.net/clinical-trials-registry/NCT01979406
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Anthrax, Phase 1 Study, Pregnancy Registry, Vaccine, Biothrax
